Novartis Investigative Site

Essen-Werden 45239

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia (AML), Hodgkin's Lymphoma

Studies at this site

• A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML) — Completed
• A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) — Completed